Medical Device and Diagnostic Industry (MD+DI): Location Matters: Verve Medical's Renal Pelvic Denervation Offers Targeted Relief for High Blood Pressure
Verve Medical's renal pelvic denervation therapy leverages location to deliver a targeted, minimally invasive treatment for uncontrolled hypertension.
Location Matters: Verve Medical's Renal Pelvic Denervation Offers Targeted Relief for High Blood Pressure
Medical Xpress: Targeted therapy to manage kidney complications may enable continuation of lifesaving immunotherapy
MSN: Triplet combinations of immunotherapy and targeted treatments as first-line therapy for advanced renal cell carcinoma
Triplet combinations of immunotherapy and targeted treatments as first-line therapy for advanced renal cell carcinoma
An international study led by the University of Münster found that a targeted preventive care protocol significantly reduced moderate and severe acute kidney injury in high‑risk patients after major ...
Targeted therapy to manage kidney complications may enable continuation of lifesaving immunotherapy
Firstpost: New targeted therapies could cut need for dual transplants in rare kidney disorders: Experts
New targeted therapies are transforming treatment for rare kidney disorders, offering hope of slowing disease progression and reducing the need for dialysis or transplants.
New targeted therapies could cut need for dual transplants in rare kidney disorders: Experts
Cleveland.com: OSU Wexner completes 20 kidney transplants in 2 days; 10 people helped by rare surgical chain
COLUMBUS, Ohio — A medical center at Ohio State University recently performed a rare 20-person living kidney donor transplant chain, completing 20 surgeries over two days, the university announced. It ...
OSU Wexner completes 20 kidney transplants in 2 days; 10 people helped by rare surgical chain
KEYMAKER-U03 is an international, multicenter, open-label, Phase I/II umbrella trial evaluating experimental combinations of pembrolizumab-based immunotherapy and targeted treatments for advanced ...